Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
8.48
-0.03 (-0.29%)
Jul 20, 2026, 10:17 AM EDT - Market open
Alpha Cognition Revenue
Alpha Cognition had revenue of $3.53M in the quarter ending March 31, 2026, with 20.66% growth. This brings the company's revenue in the last twelve months to $10.83M, up 269.64% year-over-year. In the year 2025, Alpha Cognition had annual revenue of $10.22M.
Revenue (ttm)
$10.83M
Revenue Growth
+269.64%
P/S Ratio
17.10
Revenue / Employee
$152,471
Employees
71
Market Cap
184.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 10.22M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Protalix BioTherapeutics | 76.38M |
| Cellectis | 75.11M |
| Voyager Therapeutics | 36.49M |
| MediWound | 14.48M |
| Camp4 Therapeutics | 3.93M |
| NRx Pharmaceuticals | 2.29M |
| Humacyte | 2.02M |
ACOG News
- 10 days ago - Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
- 10 days ago - Alpha Cognition initiated with an Outperform at Raymond James - TheFly
- 26 days ago - Alpha Cognition appoints Robert Wills as chairman of the board - TheFly
- 27 days ago - Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board - Business Wire
- 4 weeks ago - Alpha Cognition announces enrollment of first patient in Resolve - TheFly
- 4 weeks ago - Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer's Disease - Business Wire
- 5 weeks ago - Alpha Cognition reports results from Beacon real-world study of Zunevyl - TheFly
- 5 weeks ago - Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer's Disease - Business Wire